ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 978

$418K Total Retail Price of All Prescriptions

Rank: 69 out of 978

312 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

5% of this provider’s 8,604 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 525 393 1 2
LISINOPRIL 423 350 2 1
OMEPRAZOLE 421 330 3 3
HYDROCHLOROTHIAZIDE 415 383 4 5
METFORMIN HCL 396 290 5 7
METOPROLOL TARTRATE 390 347 6 10
LEVOTHYROXINE SODIUM 315 180 7 4
QUINAPRIL HCL 309 293 8 95
AMLODIPINE BESYLATE 296 276 9 6
FUROSEMIDE 283 256 10 9
GLYBURIDE 246 232 R 11 44
METOPROLOL SUCCINATE 219 184 12 13
WARFARIN SODIUM 202 168 13 11
VERAPAMIL ER 180 104 14 88
PRAVASTATIN SODIUM 165 119 15 16
BISOPROLOL-HYDROCHLOROTHIAZIDE 146 107 16 148
FLUOXETINE HCL 143 80 17 42
ATORVASTATIN CALCIUM 129 104 18 12
LOVASTATIN 127 103 19 29
GEMFIBROZIL 126 77 20 97
ALLOPURINOL 121 115 21 34
LOSARTAN POTASSIUM 113 113 22 22
ALENDRONATE SODIUM 111 98 23 20
PREDNISONE 99 92 24 47
ATENOLOL 99 76 24 8
ISOSORBIDE MONONITRATE ER 86 75 26 57
RANITIDINE HCL 86 57 26 27
OXYCODONE-ACETAMINOPHEN 85 41 S2 28 25
TAMSULOSIN HCL 84 74 29 33
SERTRALINE HCL 84 33 29 21
TRAZODONE HCL 80 51 31 18
GABAPENTIN 79 48 32 15
INSULIN SYRINGE 76 70 33 80
ACETAMINOPHEN-CODEINE 75 69 S3 34 102
LANTUS 67 67 35 40
HYDROCODONE-ACETAMINOPHEN 64 35 S3 36 17
DONEPEZIL HCL 64 64 36 26
NITROGLYCERIN PATCH 62 62 38 151
CLONIDINE HCL 61 42 39 119
IBUPROFEN 58 48 40 38
KLOR-CON M20 57 50 41 66
PANTOPRAZOLE SODIUM 57 57 41 39
ENALAPRIL MALEATE 57 32 41 64
JANTOVEN 56 56 44 184
ADVAIR DISKUS 56 56 44 35
AMITRIPTYLINE HCL 55 32 R 46 59
CITALOPRAM HBR 55 48 46 14
LIPITOR 55 46 46 84
METFORMIN HCL ER 54 43 49 48
DILTIAZEM 24HR ER 53 51 50 69
ACTOS 52 28 51 89
DIOVAN 51 39 52 43
KLOR-CON M10 51 51 52 183
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.